These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18852123

  • 21. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, Nelson C, Gleave M.
    Cancer Res; 2007 Nov 01; 67(21):10455-65. PubMed ID: 17974989
    [Abstract] [Full Text] [Related]

  • 22. Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells.
    Lazarevic B, Karlsen SJ, Saatcioglu F.
    Oncol Rep; 2008 May 01; 19(5):1231-5. PubMed ID: 18425381
    [Abstract] [Full Text] [Related]

  • 23. Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.
    Chen L, Li J, Farah E, Sarkar S, Ahmad N, Gupta S, Larner J, Liu X.
    Mol Cancer Ther; 2016 Sep 01; 15(9):2107-18. PubMed ID: 27390342
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
    Wang J, Li Z, Lin Z, Zhao B, Wang Y, Peng R, Wang M, Lu C, Shi G, Shen Y.
    Cancer Lett; 2015 Jun 28; 362(1):83-96. PubMed ID: 25813406
    [Abstract] [Full Text] [Related]

  • 30. HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis.
    Ryu HW, Shin DH, Lee DH, Choi J, Han G, Lee KY, Kwon SH.
    Cancer Lett; 2017 Apr 10; 391():162-171. PubMed ID: 28153791
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Modulating molecular chaperone Hsp90 functions through reversible acetylation.
    Aoyagi S, Archer TK.
    Trends Cell Biol; 2005 Nov 10; 15(11):565-7. PubMed ID: 16199163
    [Abstract] [Full Text] [Related]

  • 35. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.
    Saporita AJ, Ai J, Wang Z.
    Prostate; 2007 Apr 01; 67(5):509-20. PubMed ID: 17221841
    [Abstract] [Full Text] [Related]

  • 36. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone.
    Murphy PJ, Morishima Y, Kovacs JJ, Yao TP, Pratt WB.
    J Biol Chem; 2005 Oct 07; 280(40):33792-9. PubMed ID: 16087666
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.
    Jochems J, Teegarden SL, Chen Y, Boulden J, Challis C, Ben-Dor GA, Kim SF, Berton O.
    Biol Psychiatry; 2015 Feb 15; 77(4):345-55. PubMed ID: 25442004
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.